In a significant decision that clarifies the standards for determining controlling stockholder status, the Delaware Court of Chancery dismissed claims against AstraZeneca and Viela Bio’s directors in connection with Viela’s $ 3 billion sale to Horizon Therapeutics. The case, Sciannella v. AstraZeneca UK Limited et al., addressed whether AstraZeneca, which held a 26.7% stake in Viela, exercised control over the company and whether the merger was subject to business judgment review under Corwin v. KKR Financial Holdings LLC. Vice … Read the rest
Establishing the true cause of the accident is essential because you need to know who to sue, the driver or the trucking company.
Legal Reader… Read the rest
An employee working for the electric vehicle manufacturer Rivian filed a gender discrimination lawsuit after she was fired for reporting the “toxic bro culture” she was allegedly subjected to at work.
Legal Reader… Read the rest
In a November 30, 2021 opinion (here), a Delaware Superior Court judge, applying Delaware law, held that the later investigations of the insured policyholder by two regulatory agencies were unrelated to an earlier investigation of the company by one of the agencies. In making this “relatedness” determination, the court declined to apply the “fundamentally identical” standard that some Delaware courts have applied to relatedness issues, but instead applied a “meaningful linkage” test. Because relatedness disputes are so frequent, and because … Read the rest